{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:48:43Z","timestamp":1782272923640,"version":"3.54.5"},"reference-count":21,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Palliative Medicine"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients with advanced brain tumors often experience dysphagia and excessive drooling, leading to respiratory complications and a reduced quality of life. We evaluated the clinical utility of transdermal scopolamine (TS) in pediatric patients with brain tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A 5.0% scopolamine ointment was prepared in-house and applied once daily to the mastoid regions behind the ears.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Five patients (four children and one adolescent) with brain tumors received TS treatment. All patients had low Lansky\/Karnofsky performance status scores, ranging from 20 to 40. Within two weeks of treatment, four patients showed objective improvements, including reduced suctioning and oxygen requirements and alleviation of respiratory symptoms. No severe or unexpected adverse events related to TS were observed. Four patients were able to transition to home-based care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The findings of this study suggest that TS may be a safe and effective option for managing salivation in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10966218251406762","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T08:59:46Z","timestamp":1766480386000},"page":"659-662","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Transdermal Scopolamine Ointment for Reducing Salivation in Pediatric and Adolescent Patients with Brain Tumors"],"prefix":"10.1177","volume":"29","author":[{"given":"Kyogo","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Tokyo Metropolitan Children\u2019s Medical Center, Fuchu, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Tokyo Metropolitan Children\u2019s Medical Center, Fuchu, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanaka","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Tokyo Metropolitan Children\u2019s Medical Center, Fuchu, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Tokyo Metropolitan Children\u2019s Medical Center, Fuchu, Japan."},{"name":"Department of Palliative Care, Tokyo Metropolitan Children\u2019s Medical Center, Fuchu, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006981.pub3"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2024.104433"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-29.1.6"},{"key":"e_1_3_3_5_2","volume-title":"APPM Master Formulary","author":"Association for Paediatric Palliative Medicine","year":"2024","unstructured":"Association for Paediatric Palliative Medicine. APPM Master Formulary. 6th ed. 2024. Available from: https:\/\/www.appm.org.uk","edition":"6"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645060-00001"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2013.11.014"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S168353"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.04.001"},{"issue":"4","key":"e_1_3_3_10_2","first-page":"357","article-title":"[Control of drooling with scopolamine ointment for severely disabled]","volume":"26","author":"Yokoyama R","year":"1994","unstructured":"Yokoyama R, , Kawara H, , Ishii H. [Control of drooling with scopolamine ointment for severely disabled]. No To Hattatsu, 1994; 26(4):357\u2013358.","journal-title":"No To Hattatsu"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03659.x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-020-02336-x"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxab051"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002851.pub4"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010156"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.11.014"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206000235"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-313763"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/jpan.2002.36555"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b23-00561"},{"key":"e_1_3_3_21_2","unstructured":"U.S. National Library of Medicine. Scopolamine Transdermal Patch. MedlinePlus: Bethesda MD; 2025. Available from: https:\/\/medlineplus.gov\/druginfo\/meds\/a682509.html [Last accessed: October14 2025]."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00075-2024"}],"container-title":["Journal of Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10966218251406762","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10966218251406762","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10966218251406762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:26:52Z","timestamp":1782271612000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10966218251406762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"alternative-id":["10.1177\/10966218251406762"],"URL":"https:\/\/doi.org\/10.1177\/10966218251406762","relation":{},"ISSN":["1096-6218","1557-7740"],"issn-type":[{"value":"1096-6218","type":"print"},{"value":"1557-7740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}